Journal of Ophthalmic & Vision Research最新文献

{"title":"The Repeatability of Axial Length Measurements Using a Scheimpflug-based System.","authors":"Sara Sardari, Mehdi Khabazkhoob, Ebrahim Jafarzadehpur, Akbar Fotouhi","doi":"10.18502/jovr.v18i4.14551","DOIUrl":"10.18502/jovr.v18i4.14551","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the repeatability of Pentacam AXL as a Scheimpflug-based system or measuring axial length according to the age, sex, lens type, axial length value, and type of cataract.</p><p><strong>Methods: </strong>The present study was conducted using multistage cluster sampling in Tehran, Iran. Ocular biometry was performed, using the Pentacam AXL, by an experienced optometrist on all the participants. The axial length (AL) measurements were taken thrice, with a gap of 10 minutes. To evaluate the repeatability, the intraclass correlation coefficient (ICC) and the repeatability coefficient (RC) were calculated. To determine the significant difference in the repeatability index among study variables, the tolerance index (TI) was calculated.</p><p><strong>Results: </strong>In this report, 897 eyes of 677 individuals aged between 20 and 91 years (mean <math><mo>±</mo></math> SD: 64.90 <math><mo>±</mo></math> 13.62 years) were reported. The ICC of the axial length measurements was 0.981 for all cases. Based on the within-subject standard deviation, the RC was 0.401. The ICC was 0.976 and 0.985 in men and women, respectively. The TI showed better RC of measurements among females. The ICC decreased from 0.999 in participants under 40 years to 0.973 in individuals over 60 years of age. The TI showed a decrease in RC with advancing age. The RC was worse in eyes with nuclear cataracts; the RC was also worse in the first quartile of the signal-to-noise ratio (SNR) compared to the other SNR quartiles.</p><p><strong>Conclusion: </strong>The Scheimpflug-based systemPentacam AXL had high repeatability in measuring axial length. Some variables such as male gender, older age, and nuclear cataract were associated with reduced repeatability of the measurements. A higher SNR was associated with better repeatability of the axial length measurements.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 4","pages":"396-404"},"PeriodicalIF":2.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139512982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of COVID-19 on Ophthalmology Practice: Changes and Controversies in Endophthalmitis Risk.","authors":"Mohammad Riazi","doi":"10.18502/jovr.v18i3.13771","DOIUrl":"10.18502/jovr.v18i3.13771","url":null,"abstract":"","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"249-251"},"PeriodicalIF":2.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk of Induction of Corneal Neovascularization with Topical Erythropoietin: An Animal Safety Study.","authors":"Sepehr Feizi, Mozhgan Rezaei Kanavi, Mohammad Abolhosseini, Seyed-Mohamadmehdi Moshtaghion, Hamed Esfandiari","doi":"10.18502/jovr.v18i3.13772","DOIUrl":"10.18502/jovr.v18i3.13772","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the pro-angiogenic effect of topical erythropoietin on cornea in chemical burn-injured rabbit eyes.</p><p><strong>Methods: </strong>The corneal alkali-burn injury was induced in 10 eyes of 10 rabbits using filter paper saturated with 1.0 mol sodium hydroxide. The eyes were categorized into the treatment group (<i>n</i> = 5) that received topical erythropoietin (3000 IU/mL) every 8 hr for one month versus the control group (<i>n</i> = 5) that received normal saline every 8 hr for one month. All eyes were treated with topical ciprofloxacin every 8 hr until corneal re-epithelialization was complete. Corneal epithelial defects, stromal opacity, and neovascularization were evaluated after the injury. At the conclusion of the study, the rabbits were euthanized and their corneas were submitted to histopathological examination.</p><p><strong>Results: </strong>Baseline characteristics including the rabbits' weight and the severity of corneal injury were comparable in two groups. Time to complete corneal re-epithelialization was 37 days in the treatment group and 45 days in the control group (<i>P</i> = 0.83). There was no significant difference between the groups in the rate of epithelial healing or corneal opacification. Clinical and microscopic corneal neovascularization was observed in one eye (20%) in the treatment group and two eyes (40%) in the control group (<i>P</i> = 0.49).</p><p><strong>Conclusion: </strong>Recombinant human erythropoietin administered topically did not induce vessel formation in rabbit corneas after chemical burn.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"252-259"},"PeriodicalIF":2.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quaternary Knot Technique: Suture Knot Burial without Scleral Flap or Incision for Trans-scleral Fixation.","authors":"Levent Dogan,&nbsp;Ibrahim Edhem Yilmaz","doi":"10.18502/jovr.v18i3.13784","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13784","url":null,"abstract":"<p><p>Despite the introduction of novel sutureless posterior chamber intraocular lens (IOL) fixation techniques, some conditions still require suture-assisted scleral fixation. If the scleral fixation suture knot is left directly under the conjunctiva, it may become exposed, resulting in an increased risk of endophthalmitis. To avoid this problem, we offer a new alternative, simple, and safe way for burying the end of the suture using knots in this report.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"342-347"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Novel and Low-cost Approach for Intravitreal Injection in an Experimental Model of Endophthalmitis.","authors":"Dhanwini Rudraprasad,&nbsp;Jaishree Gandhi,&nbsp;Poonam Naik,&nbsp;Milind N Naik,&nbsp;Chenchu Naidu,&nbsp;Dilip Kumar Mishra,&nbsp;Joveeta Joseph","doi":"10.18502/jovr.v18i3.13775","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13775","url":null,"abstract":"<p><strong>Purpose: </strong>Animal models are necessary in understanding the pathogenesis of endophthalmitis and are also necessary to assist the development of new therapeutics for this sight-threatening ocular inflammation. Hamilton syringes are usually preferred to inject pathogens when performing experiments on test subjects, however, this method has technical and financial disadvantages. In this study, we report the findings and assess the related benefits of applying a novel low-cost intravitreal injection technique to initiate endophthalmitis in a mouse model while using the Eppendorf tip and a 26G needle.</p><p><strong>Methods: </strong>The 18-hr culture of clinical isolates of bacteria (<i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>) and fungus (<i>Aspergillus flavus</i> and <i>Candida albicans</i>) were resuspended to a final concentration of 10,000 colony forming units (CFU)/1 µL which were separately injected intravitreally into C57BL/6 mice (6-8 weeks) using a 0.1-2.5µL pipette attached to the modified Eppendorf tip with a 26G needle. The contralateral eye served as vehicle/uninjected control. Disease progression was determined by assessing the corneal haze, opacity, bacterial burden, and retinal histology of the eyes used in the model. Following euthanization, bacteria-infected mice were enucleated after 24 hr of the initial injection, and fungus-infected mice after 72 hr.</p><p><strong>Results: </strong>Of the 50 mice injected, the modified technique was successful in 48 mice. Two mice were excluded due to cataract formed by accidental injury to the lens. The experimental endophthalmitis mice model successfully mimicked the natural clinical course. Clinical assessment and histopathology confirmed the influx of inflammatory cells into the posterior segment of the eye along with dissolution of retinal architecture.</p><p><strong>Conclusion: </strong>Our novel method of injection using a modified Eppendorf tip and 26G needle yielded a cost-effective mouse model of clinical endophthalmitis, resulting in reproducible infection for understanding various aspects of its pathobiology.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"272-282"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraocular Pressure Values using IcareⓇ Rebound Tonometer and Correlation with Postconceptional Age in Premature Infants.","authors":"Catarina Monteiro,&nbsp;Maria Vivas,&nbsp;Júlio Almeida,&nbsp;Mário Ramalho,&nbsp;Mafalda Mota,&nbsp;Susana Teixeira,&nbsp;Isabel Prieto","doi":"10.18502/jovr.v18i3.13774","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13774","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimedto determine a normative range of intraocular pressure (IOP) values measured with Icare rebound tonometer in premature infants and evaluate IOP variation over time and its correlation with the progression of postconceptional age (PCA). By doing so, we also evaluated advantages of this IOP-measuring method in this population when compared to more traditional methods.</p><p><strong>Methods: </strong>We conducted a single-center prospective study that included premature infants (gestational age <math><mo>≤</mo></math>32 weeks) who were admitted to the neonatal intensive care unit (NICU) in Hospital Professor Doutor Fernando Fonseca. The study took place between January and December 2021. IOP was measured using Icare tonometer on the occasion of the first retinopathy of prematurity (ROP) screening requested by the NICU and again after a two-week interval if PCA was still <math><mo>≤</mo></math>37 weeks. IOP measurements were stopped at 37 weeks or if the infant was discharged. The evaluated outcomes were mean IOP values and their correlation with PCA.</p><p><strong>Results: </strong>Thirty-four eyes of 17 preterm infants with a mean gestational age of 29.4 <math><mo>±</mo></math> 2.3 weeks and a mean birth weight of 1222.9 <math><mo>±</mo></math> 361.9 gr were evaluated. The mean IOP registered was 16.1 <math><mo>±</mo></math> 6.4 mmHg, with a median value of 15.3 mmHg. The top 90<math><msup><mrow></mrow><mrow><mi>t</mi><mi>h</mi></mrow></msup></math> percentile was 22.1 mmHg and the bottom 10<math><msup><mrow></mrow><mrow><mi>t</mi><mi>h</mi></mrow></msup></math> percentile was 9.0 mmHg. The average IOP reduction was 4.8 <math><mo>±</mo></math> 6.7 mmHg (<i>P</i> = 0.0019) within the two-week interval of PCA.</p><p><strong>Conclusion: </strong>The mean IOP in premature infants was 16.1 <math><mo>±</mo></math> 6.4 mmHg and this value significantly decreased by 4.8 <math><mo>±</mo></math> 6.7 mmHg every two weeks of PCA.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"267-271"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eye Care Utilization among Older Subjects with Visual Impairment in Northwest Ethiopia.","authors":"Aragaw Kegne Assaye,&nbsp;Melkamu Temeselew Tegegn,&nbsp;Gizachew Tilahun Belete","doi":"10.18502/jovr.v18i3.13779","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13779","url":null,"abstract":"<p><strong>Purpose: </strong>To find out the level of eye care service utilization and its determinants among the elderly visually impaired populations while visiting ophthalmic outreach locations in North-Western Ethiopia, 2021.</p><p><strong>Methods: </strong>An ophthalmic outreach-based cross-sectional study was conducted on 852 visually impaired older people. Participants were selected by using a systematic random sampling method from January to July 2021. Data were collected by using an interviewer-administered questionnaire and an ocular examination. The collected data were entered into the Epi Info 7, and analyzed using SPSS 20. A binary logistic regression was fitted.</p><p><strong>Results: </strong>A total of 821 participants, with a response rate of 96.5%, were included in the study. The utilization of eye care services within the past two years prior to the study was 21.1% (95 % CI: 18.2-23.9). Having systemic disease (AOR = 3.2, 95% CI: 1.5-7.0), being a spectacle wearer (AOR = 4.5, 95% CI: 2.0-9.4), having visual impairment at distance (AOR = 2.9; 95% CI: 1.5-5.6), being blind (AOR = 2.9; 95% CI: 1.5-5.6), duration of visual impairment <math><mo>≤</mo></math>1 year (AOR = 2.5; 95% CI: 1.3-4.9) were all significantly associated.</p><p><strong>Conclusion: </strong>In this study, utilization of eye care services was low. Being visually impaired at distance, being blind, recent onset of visual impairment, being a spectacle wearer, and having systemic disease were all related to the use of eye care services. The commonest barriers to utilization of eye care services were financial scarcity and long distances between eye care facilities.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"306-317"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stem Cell Therapy in Stargardt Disease: A Systematic Review.","authors":"Atousa Moghadam Fard,&nbsp;Reza Mirshahi,&nbsp;Masood Naseripour,&nbsp;Khalil Ghasemi Falavarjani","doi":"10.18502/jovr.v18i3.13780","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13780","url":null,"abstract":"<p><p>This article aimed to review current literature on the safety and efficacy of stem cell therapy in Stargardt disease. A comprehensive literature search was performed, and two animal and eleven human clinical trials were retrieved. These studies utilized different kinds of stem cells, including human or mouse embryonic stem cells, mesenchymal stem cells, bone marrow mononuclear fraction, and autologous bone marrow-derived stem cells. In addition, different injection techniques including subretinal, intravitreal, and suprachoroidal space injections have been evaluated. Although stem cell therapy holds promise in improving visual function in patients with Stargardt disease, further investigation is needed to determine the long-term benefits, safety, and efficacy in determining the best delivery method and selecting the most appropriate stem cell type.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"318-327"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical and Autofluorescence Findings in Eyes with Pinguecula and Pterygium.","authors":"Amir-Hooshang Beheshtnejad,&nbsp;Hamed Ghassemi,&nbsp;Hossein Abdolkhalegh,&nbsp;Mehrnaz Atighehchian","doi":"10.18502/jovr.v18i3.13773","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13773","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the autofluorescence size and properties of pterygium and pinguecula by anterior segment autofluorescence (AS-AF) imaging and demonstrate the difference of autofluorescence size presented in AS-AF imaging compared to the extend size of the conjunctival lesion measured by anterior segment slit-lamp photography (AS-SLE).</p><p><strong>Methods: </strong>Twenty-five patients with primary pterygium and twenty-five with pinguecula were included in the study. In addition, 25 normal subjects were also enrolled as the control group. The AS-AF characteristics of pterygium and pinguecula lesions were analyzed. The size of lesions displayed in the AS-SLE photography versus the AS-AF images were also compared. AS-AF images were obtained using a Heidelberg retina angiograph which focused on the anterior segment. AS-SLE photography was acquired using a digital imaging system (BX900 HAAG-STREIT).</p><p><strong>Results: </strong>There were 44 (58.7%) male and 31 (41.3%) female patients; 19 (76%) and 20 (80%) patients had bilateral pterygium and pinguecula, respectively. All pinguecula lesions reflected hyperautofluorescence pattern in the AS-AF imaging. In 24 (96%) patients, the hyperautofluoresecence pattern was larger than the size of the clinical lesions displayed with the AS-SLE photography. Twenty-one (84%) patients with pterygium reflected a hyperautofluorescence pattern in AS-AF images; in one (4%) patient, the hyperautofluorescence pattern was larger than the clinical lesion size and four (16%) patients had no autofluorescence patterns in the AS-AF images. In the control group, in 14 (56%) subjects, a hypoautofluorescent pattern was revealed in the conjunctiva in AS-AF images. However, in 11 (44%) patients, hyperautofluorescence patterns were detected.</p><p><strong>Conclusion: </strong>AS-AF is a useful modality to monitor vascularization in conjunctival lesions. Pingueculae and pterygium show hyperautofluorescence in AS-AF imaging. The real size of the pinguecula lesions may be estimated with AS-AF characteristics, mostly presenting larger than the area size in AS-SLE photography. The autofluorescence size of the pterygium is smaller than the extent of visible pterygium in slit-lamp photography.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"260-266"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic.","authors":"Saeed Karimi,&nbsp;Homayoun Nikkhah,&nbsp;Amir Mohammadzadeh,&nbsp;Alireza Ramezani,&nbsp;Iman Ansari,&nbsp;Hosein Nouri,&nbsp;Seyed-Hossein Abtahi","doi":"10.18502/jovr.v18i3.13776","DOIUrl":"https://doi.org/10.18502/jovr.v18i3.13776","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the added risk of acute endophthalmitis after intravitreal injections associated with the widespread use of face masks during the COVID-19 pandemic.</p><p><strong>Methods: </strong>In this retrospective, single-center study, records of patients with acute endophthalmitis following intravitreal bevacizumab (IVB) injections during the pre-COVID era-that is, March 1<math><msup><mrow></mrow><mtext>st</mtext></msup></math>, 2013 to October 31<math><msup><mrow></mrow><mtext>st</mtext></msup></math>, 2019 -and the COVID-19 era-that is, March 1<math><msup><mrow></mrow><mtext>st</mtext></msup></math>, 2020 to April 1<math><msup><mrow></mrow><mtext>st</mtext></msup></math>, 2021 -were reviewed and compared.</p><p><strong>Results: </strong>A total of 28,085 IVB injections were performed during the pre-COVID era; nine eyes of nine patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.032% (3.2 in 10,000 injections). In the COVID era, 10,717 IVB injections were performed; four eyes of four patients developed acute post-IVB endophthalmitis in this era, giving an overall incidence of 0.037% (3.7 in 10,000 injections). The incidences of post-IVB endophthalmitis during these two eras were not statistically significantly different (<i>P</i> = 0.779).</p><p><strong>Conclusion: </strong>Face masking protocols seem unlikely to impose any additional risk of post-IVB endophthalmitis.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"18 3","pages":"283-288"},"PeriodicalIF":2.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}